Ospedale San Gerardo

Running trials

• Recruiting

  heaRtInsiGHT Alert guIDE: RightAIDE Application of the HeartInsight Acute Heart Failure Predictor in Routine Clinical Practice: Organizational Models and Workflow.

  NCT07281859· Source

• Recruiting

  Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera

  NCT06516406· Source

• Active, not recruiting

  Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT

  NCT04476199· Phase 2· Source

• Recruiting

  Protocol ITANET - Registry

  NCT04282083· Source

• Active, not recruiting

  Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

  NCT02922036· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Neuroendocrine tumours1 recruiting
• Pancreatic cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

  NCT06525675· Source

• Completed

  Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer

  NCT05173103· Source

• Completed

  Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies

  NCT04400981· Source

• Completed

  ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL

  NCT04603183· Phase 2· Source

• Completed

  Follow-up in Early and Locally Advanced Breast Cancer Patients

  NCT03859453· Source

• Completed

  A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer

  NCT04148911· Phase 3· Source

• Terminated

  Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer)

  NCT03891576· Phase 2· Source

• Completed

  Clinical and Laboratory Characteristics of Polycythemia Vera

  NCT06134102· Source

• Completed

  Comparison of CRT-D and CRT-DX Systems (CRT-NEXT)

  NCT03587064· Source

• Completed

  Atezolizumab Trial in Endometrial Cancer - AtTEnd

  NCT03603184· Phase 3· Source

• Completed

  Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

  NCT03556839· Phase 3· Source

• Completed

  A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

  NCT03371017· Phase 3· Source